Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy

Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy

Abstract Gastric cancer is characterized by high morbidity and mortality worldwide. Early-stage gastric cancer is mainly treated with surgery, while for advanced gastric cancer, the current treatment options remain insufficient. In the 2022 NCCN Guidelines for Gastric Cancer, immunotherapy is listed...

Full description

Bibliographic Details
Main Authors: Hongzhen Cai, Man Li, Ruiyi Deng, Mopei Wang, Yanyan Shi
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Biomarker Research
Subjects:
Gastric cancer
Immunotherapy
Anti-PD-1
Biomarker
Checkpoint inhibitor
Online Access:https://doi.org/10.1186/s40364-022-00413-0

Internet

https://doi.org/10.1186/s40364-022-00413-0

Similar Items